Could Dynamic Duo Diageo plc And GlaxoSmithKline plc Make You A Millionaire?

GlaxoSmithKline plc (LON: GSK) and Diageo plc (LON: DGE) are the perfect shares to get rich slowly.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

The £1m mark is a key goal for many investors and the most effective way to hit this target is slowly, without taking excessive risks. Personally, I think the best investments to help you do this are GlaxoSmithKline (LSE: GSK) and Diageo (LSE: DGE). 

Glaxo and Diageo won’t run you into Warren Buffett overnight, but they will help you meet your savings goals. Indeed, his first rule of investing is “don’t lose money”, the second rule is “don’t forget rule one”. Losing money can be extremely damaging to you investment returns and even a small 10% loss can hold you back for years.

And neither Glaxo nor Diageo will cost you money. Their shares may fall in the short term but over the long term they should push steadily higher.

Defensive companies

You see, Diageo and Glaxo are defensive companies. Diageo is the world’s largest alcoholic beverage company, with some of the world’s bestselling spirit brands in its drinks cabinet. Meanwhile, Glaxo is a leading pharmaceutical company, which manufactures a broad selection of every day treatments and consumer goods that have become consumer staples over the years.

So, Diageo and Glaxo are not going to go out of business any time and it’s highly unlikely that either company will see its share price go to zero. 

With this being the case, investors can buy and hold the two companies’ shares in their portfolios over the long term without much worry. What’s more, both Glaxo and Diageo have a history of returning the majority of their earnings to investors in the form of dividends. Through the power of compounding, these cash returns have helped accelerate total returns achieved from the investments.

The power of compounding

If you invested £1,000 in Diageo during 1995, with dividends invested that stake would be worth £5,200 today, an average annual return of 10.10%. Similarly, if you’d purchased £1,000 of Glaxo stock during 1995, that stake would be worth £4,412 today, after achieving an average annual return of 7.9%. 

These figures may not seem like much at first glance, but for the long-term investor the returns really start to add up. Over four decades, a £1,000 investment in Glaxo, made during 1995 will be worth around £23,000 by 2035. However, the Diageo investment would worth a staggering £55,000 by 2035.

If you were to invest £1,000 in each company and add an additional £1,000 to each holding every year, based on the above rate of growth, your portfolio would be worth just under £1m by 2035.

Based on these numbers then, Glaxo and Diageo could make you a millionaire. 

Glaxo currently trades at a forward P/E of 17.3, which seems expensive but the company trades at a discount of about 10% to its international peers. The company’s shares offer a yield of 4.9%. Diageo currently trades at a forward P/E of 20.4, in line with its international peers and the company offers a dividend yield of 2.6%. 

Rupert Hargreaves owns shares of GlaxoSmithKline. The Motley Fool UK has recommended GlaxoSmithKline. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Businessman hand stacking money coins with virtual percentage icons
Investing Articles

£5,000 invested in Tesco shares 5 years ago is now worth this much…

Tesco share price growth has been just part of the total profit picture, but can our biggest supermarket handle the…

Read more »

Investing Articles

Here’s why I’m bullish on the FTSE 100 for 2026

There's every chance the FTSE 100 will set new record highs next year. In this article, our Foolish author takes…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Growth Shares

UK interest rates fall again! Here’s why the Barclays share price could struggle

Jon Smith explains why the Bank of England's latest move today could spell trouble for the Barclays share price over…

Read more »

Man hanging in the balance over a log at seaside in Scotland
Investing Articles

2 out-of-favour FTSE 250 stocks set for a potential turnaround in 2026

These famous retail stocks from the FTSE 250 index have crashed in 2025. Here's why 2026 might turn out to…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

Down over 30% this year, could these 3 UK shares bounce back in 2026?

Christopher Ruane digs into a trio of UK shares that have performed poorly this year in search of possible bargains…

Read more »

Mature people enjoying time together during road trip
Investing Articles

Yields up to 8.5%! Should I buy even more Legal & General, M&G and Phoenix shares?

Harvey Jones is getting a brilliant rate of dividend income from his Phoenix shares, and a surprising amount of capital…

Read more »

Light trails from traffic moving down The Mound in central Edinburgh, Scotland during December
Investing Articles

Up 7.5% in a week but with P/Es below 8! Are JD Sports Fashion and easyJet shares ready to take off?

easyJet shares have laboured in 2025, but suddenly they're flying. The same goes for JD Sports Fashion. Both still look…

Read more »

US Stock

I think this could be the best no-brainer S&P 500 purchase to consider for 2026

Jon Smith reveals a stock from the S&P 500 that he feels has the biggest potential to outperform the index,…

Read more »